R&D Trends

CRISPR Therapeutics, Casebia Therapeutics partner with StrideBio

Tuesday, April 18, 2017

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer for developing CRISPR-based therapeutics in select disease areas, have signed a collaboration agreement with StrideBio, a U.S.-based company developing novel AAV vectors for in vivo gene delivery applications.

[Read More]

HitGen, Pfizer collaborate to build and screen novel DNA-encoded libraries

Tuesday, April 18, 2017

HitGen has entered into a multi-year research collaboration and license agreement with Pfizer to build and screen novel DNA-encoded libraries (DELs) in order to potentially discover unique small molecule leads to be used in drug development. Through the collaboration, HitGen and Pfizer scientists will apply HitGen’s advanced technology platform and research capabilities in the design, synthesis and screening of multiple proprietary DELs for Pfizer’s drug discovery efforts.

[Read More]

Bristol-Myers Squibb, Nordic Bioscience collaborate on fibrosis biomarker technology

Tuesday, April 18, 2017

Bristol-Myers Squibb and Nordic Bioscience, a Danish company specializing in biomarker technologies, announced a collaboration agreement to develop biomarker technology to potentially aid in the diagnosis and monitoring of fibrotic diseases including non-alcoholic steatohepatitis (NASH). Nordic Bioscience has over 25 years’ experience in biomarker development and clinical trials with extensive expertise in rheumatology and fibrosis. A biomarker is a molecule that may be used to diagnose a disease, or predict disease progression and indicate response to therapy.

[Read More]

Greater Gift Initiative partners with INC Research

Friday, April 14, 2017

The Greater Gift Initiative (GGI), a Winston-Salem, NC 501(c)3 nonprofit, partnered with INC Research, a global phase I to IV CRO with experience in vaccine clinical research. GGI’s mission is to advance global health and highlight the greater good of clinical trial participation by gifting a vaccine to a child in need in honor of each clinical trial volunteer. The vision of GGI is to serve as a philanthropic connector among clinical trial sites, individual investigators, CROs and sponsors by conveying a unified message to the clinical volunteer community that their participation does matter.

[Read More]

Novaseek Research, CoxHealth partner on biomedical and clinical research

Friday, April 14, 2017

Novaseek Research, a health IT for life sciences company, has partnered with CoxHealth, an integrated health systems, to support and expand biomedical and clinical research activity. Through this collaboration, CoxHealth and Novaseek will utilize Novaseek’s Clinical Data Network for Research (CDNR) platform to procure, with patient consent and authorization, biospecimens and associated real world clinical data in pursuit of accelerating medical innovation. The agreement also expands Novaseek’s national network of healthcare organizations that supports discovery, translational medicine, observational and clinical studies.

[Read More]